Both tranexamic acid and kojic acid are used to treat hyperpigmentation. Both appear in serums and creams targeting dark spots, melasma, and uneven tone. But they work through completely different mechanisms, perform better on different types of pigmentation, and carry different risk profiles.
Understanding what each one actually does makes it straightforward to choose the right one for your skin, or to use both in a way that makes sense.
How Tranexamic Acid and Kojic Acid Work on Pigmentation
Kojic acid works directly at the enzyme level. Melanin production is controlled by tyrosinase, a copper-containing enzyme. Kojic acid chelates (binds to) the copper ions inside tyrosinase, disabling the enzyme and preventing it from producing melanin. It is one of the most potent natural tyrosinase inhibitors available in over-the-counter skincare, with visible results typically appearing within four to eight weeks of consistent use.
Tranexamic acid works at an entirely different stage. It was originally developed as a medication to reduce surgical bleeding by blocking a protein called plasminogen. In the skin, plasminogen is involved in a signalling chain that tells melanocytes to produce more melanin in response to UV radiation and inflammation. By blocking this signalling chain, tranexamic acid reduces the communication between skin cells that triggers melanin overproduction. It does not inhibit tyrosinase directly. Instead, it cuts off the upstream signal that activates melanin production in the first place.
This distinction matters because the two ingredients are addressing the same visible problem through independent pathways, which is why combining them works better than using either alone.
What Tranexamic Acid Does Best
Tranexamic acid’s unique strength is in treating the underlying triggers of pigmentation rather than just the enzyme producing it.
Melasma is the condition where tranexamic acid has the strongest clinical evidence. Melasma is driven by a combination of hormonal influence, UV exposure, and inflammatory signalling in the skin. Because tranexamic acid interrupts the plasminogen pathway that activates melanocytes in response to these triggers, it addresses the root cause rather than just the output. Multiple clinical studies, including a 2017 randomised controlled trial comparing topical tranexamic acid to hydroquinone for melasma, have demonstrated comparable results with a significantly better safety profile.
Tranexamic acid also has documented effects on post-inflammatory hyperpigmentation (PIH) because inflammation itself activates the same plasminogen pathway. When the skin is inflamed by acne, injury, or irritation, prostaglandins and other inflammatory messengers activate melanocytes through the plasminogen system. Tranexamic acid intercepts this, which is why it is increasingly used in routines for acne-prone skin with recurring PIH.
It is stable, non-irritating, does not increase photosensitivity, and is suitable for daily use morning and evening by most skin types. For darker skin tones in particular, this tolerability profile is important. Ingredients that cause irritation risk triggering more PIH, something tranexamic acid avoids.
Effective concentration in skincare: 2 to 5%. Results typically become visible at eight to twelve weeks.
What Kojic Acid Does Best
Kojic acid is a naturally occurring compound produced by fungi, including during the fermentation of sake. It has a long track record in brightening products and clinical literature, with measurable tyrosinase inhibition at concentrations of 1 to 2% in topical products.
Its direct tyrosinase inhibition makes it effective for surface-level pigmentation, including sun spots, uneven tone, and general hyperpigmentation where overactive tyrosinase is the primary driver. Because it blocks the enzyme itself rather than an upstream signal, it can work on any pigmentation that depends on tyrosinase activity.
Kojic acid also has antioxidant and antimicrobial properties, which add minor ancillary benefits beyond brightening.
However, kojic acid comes with two practical limitations worth knowing before choosing it.
The first is stability. Kojic acid is unstable and oxidises readily when exposed to light and air, turning products yellow or brown. An oxidised product delivers significantly reduced activity. This is why kojic acid is often found in dark packaging or combined with stabilising ingredients, and why kojic dipalmitate, a more stable ester form, appears in many newer formulations.
The second is irritation and sensitisation potential. The EU Scientific Committee on Consumer Safety reviewed kojic acid in 2021 and permits it at a maximum of 1% in leave-on face and hand products due to sensitisation risk at higher concentrations. At 1 to 2%, most people tolerate it well, but a meaningful subset experience contact dermatitis, redness, or increased sensitivity, particularly with prolonged use. This makes kojic acid less suitable as a long-term daily staple than tranexamic acid, and less appropriate for already-reactive skin.
Tranexamic Acid vs Kojic Acid: Which Is Better for Your Skin Concern?
Melasma: Tranexamic acid is the stronger choice. Its mechanism directly addresses the hormonal and inflammatory signalling pathways that drive melasma, which kojic acid does not reach. Clinical studies specifically on melasma consistently favour tranexamic acid, particularly for cases driven by hormonal changes or recurring UV stimulation.
Post-acne dark marks and PIH: Tranexamic acid again, particularly for reactive or darker skin tones. It interrupts the inflammatory trigger for PIH at source, while kojic acid’s direct tyrosinase inhibition can only slow production once the signal has already been sent. Kojic acid can also cause the irritation that drives more PIH in sensitive skin.
General sun spots and surface pigmentation: Kojic acid can produce faster visible results here, typically within four to six weeks, because its direct tyrosinase inhibition acts immediately at the enzyme level. For straightforward surface-level brightening without complex underlying triggers, it is effective and quick-acting.
Sensitive or reactive skin: Tranexamic acid is significantly safer. Kojic acid’s sensitisation potential makes it a riskier choice for skin that is already prone to reactivity.
Darker skin tones (Fitzpatrick IV to VI): Tranexamic acid is preferred as the primary brightening active. Its non-irritating profile avoids the risk of triggering more PIH that exists with any irritating ingredient. Kojic acid can be used alongside it at controlled concentrations but requires careful introduction.
Long-term daily maintenance: Tranexamic acid, because of its stability and lower sensitisation risk. Kojic acid is better suited to time-limited treatment than to indefinite daily use.
Can You Use Tranexamic Acid and Kojic Acid Together?
Yes, and it is a well-supported combination. Because they work at different points in the pigmentation process, using both simultaneously covers more of the brightening pathway.
Tranexamic acid reduces the signalling that triggers melanin production. Kojic acid reduces the activity of the enzyme that produces it. Together, they address two independent mechanisms, making the combination more effective than either ingredient alone for most types of hyperpigmentation.
A clinical study by Desai et al. evaluated a serum containing tranexamic acid, kojic acid, and niacinamide for facial pigmentation and found it effective at evening skin tone, particularly in skin of colour, with minimal adverse effects. SkinCeuticals’ Discoloration Defense, which combines 1% kojic acid with tranexamic acid and niacinamide, was specifically tested on Fitzpatrick IV to VI skin tones with positive results.
When using both in the same routine, apply the lighter, water-based product first and follow with a moisturiser and daily SPF. There are no adverse interactions between the two ingredients.
The Role of SPF in Any Brightening Routine Using These Ingredients
Neither ingredient is a substitute for sun protection, and both will underperform without it.
UV exposure activates the plasminogen pathway that tranexamic acid is trying to block. It also stimulates tyrosinase activity that kojic acid is trying to inhibit. Unprotected daily sun exposure restimulates the very processes both ingredients are working to suppress.
Broad spectrum SPF 50 every morning is not an optional addition to a brightening routine. It is the step that determines whether the brightening actives can work at all. Without it, results will be slow, inconsistent, and partial regardless of what combination of actives you are using.
How to Choose Between Tranexamic Acid and Kojic Acid
| Skin Concern | Better Choice |
|---|---|
| Melasma and hormonal pigmentation | Tranexamic acid |
| Post-inflammatory hyperpigmentation (PIH) | Tranexamic acid |
| General sun spots and surface brightening | Kojic acid (faster results) |
| Sensitive or reactive skin | Tranexamic acid |
| Darker skin tones (Fitzpatrick IV to VI) | Tranexamic acid as primary active |
| Short-term targeted treatment | Kojic acid |
| Long-term daily maintenance | Tranexamic acid |
| Both together | Effective and supported combination |
How to Read Product Labels for Both Ingredients
Tranexamic acid is listed as tranexamic acid. Look for it near the top of the ingredient list, ideally at a stated concentration of 2 to 5%. Products listing it near the bottom at undisclosed concentrations are likely underdosed for visible brightening.
Kojic acid is listed as kojic acid or, in its more stable ester form, kojic dipalmitate. The EU limits leave-on face products to a maximum of 1% kojic acid. Products claiming significantly higher percentages for leave-on use are outside the regulatory safety limit in the EU. If kojic dipalmitate is listed, note that its conversion to active kojic acid on skin is not fully characterised in published research, so efficacy claims for the ester form carry more uncertainty than for the free acid.
Frequently Asked Questions
Which is better for melasma: tranexamic acid or kojic acid? Tranexamic acid has stronger and more specific clinical evidence for melasma. Its mechanism targets the hormonal and UV-triggered signalling pathways that drive melasma, which kojic acid’s tyrosinase inhibition does not address.
Can tranexamic acid and kojic acid be used together? Yes. They work through independent mechanisms and are complementary rather than redundant. Using both covers more of the pigmentation pathway than either does alone. Clinical formulations combining the two with niacinamide have shown strong results for skin of colour.
Is kojic acid safe for long-term use? At 1 to 2%, it is well tolerated by most people for defined treatment periods. For indefinite daily long-term use, tranexamic acid is a more conservative choice due to kojic acid’s sensitisation potential at higher concentrations and its stability limitations.
How long does each ingredient take to work? Kojic acid typically shows visible brightening within four to six weeks. Tranexamic acid, particularly for melasma and PIH, generally requires eight to twelve weeks of consistent use. Both need to be used alongside daily SPF to deliver results.
Is tranexamic acid safe for all skin types? Yes. Tranexamic acid has one of the most consistently favourable safety profiles of any brightening ingredient, and is suitable for sensitive skin, darker skin tones, and use during pregnancy (though always confirm with a healthcare provider before starting any new active while pregnant).
The Bottom Line: Tranexamic Acid vs Kojic Acid
Tranexamic acid is the more versatile, safer, and better-evidenced choice for melasma, PIH, and any pigmentation with an inflammatory or hormonal driver. Its mechanism is unique among common brightening ingredients, its tolerability is excellent, and its clinical evidence for the most stubborn forms of hyperpigmentation is the strongest of the two.
Kojic acid is faster-acting on surface-level pigmentation and delivers direct tyrosinase inhibition that tranexamic acid does not provide. For general brightening and sun spot treatment, it is effective and well-established. Its main limitations are formulation stability and sensitisation potential with prolonged use.
For most people dealing with persistent hyperpigmentation, the best approach combines both: tranexamic acid as the daily foundation for its anti-inflammatory, anti-melanogenic signalling, and kojic acid as a targeted booster for surface brightening and tyrosinase inhibition. Add niacinamide to block melanin transfer, apply daily SPF without fail, and give the routine at least eight to twelve weeks before assessing results.
